Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma
Clinical trial NCT07078500 · RECRUITING
Trial details
- NCT number
- NCT07078500
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-05
- Primary completion
- 2026-10-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.